Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 4

Serum pentachlorophenol levels in women with diminished ovarian reserve: a prospective cross-sectional case-control study

Emel Özalp(Ankara Etlik Şehir Hastanesi)0009-0004-9313-5210
Kubilay Çanga(Etlik Şehir Hastanesi)0009-0002-1881-1170
Berna Seyhan(Etlik Şehir Hastanesi)0009-0000-7405-3840
İnci Kahyaoğlu(Etlik Şehir Hastanesi)0000-0002-2283-9128
Pages
—
Publication Date
2026-07-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because the analyses were exploratory, unadjusted, and based on multiple correlation tests, the results should be interpreted cautiously.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Pentachlorophenol (PCP) is a persistent phenolic chemical with harmful effects on the endocrine system.
📊
Key Findings & Data:Methods: This prospective cross-sectional case-control study enrolled 120 women aged 18-45 years who were evaluated in an in vitro fertilization unit.
💡
Conclusion & Impact:Because the analyses were exploratory, unadjusted, and based on multiple correlation tests, the results should be interpreted cautiously.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pentachlorophenol · diminished ovarian reserve · anti-Müllerian hormone

Abstract

Aims: Pentachlorophenol (PCP) is a persistent phenolic chemical with harmful effects on the endocrine system. Although its causal relationship with ovarian reserve has not been fully established, it has been associated with reduced ovarian reserve. However, many cases remain unexplained. This study aimed to evaluate whether serum PCP levels differed between women with diminished ovarian reserve (DOR) and women with normal ovarian reserve. Methods: This prospective cross-sectional case-control study enrolled 120 women aged 18-45 years who were evaluated in an in vitro fertilization unit. Sixty women with anti-Müllerian hormone (AMH) 1.1 ng/ml formed the control group. Demographic, reproductive, and laboratory characteristics were recorded before treatment. Serum samples were stored at -80°C. PCP concentrations were measured with a competitive ELISA following liquid-liquid extraction. Because the assay kit had not been validated for serum, additional analytical validation was performed, including recovery, limit of detection, limit of quantification, and duplicate precision testing. Results: Age was similar between the DOR and control groups (33.1±5.9 vs 32.1±6.4 years; p=0.393). Body-mass index was higher in the DOR group (29.25±2.68 vs 27.45±2.92 kg/m²; p<0.001). Median AMH was markedly lower in the DOR group [0.51 (0.59) vs 2.78 (1.74) ng/ml; p<0.001]. Median serum PCP was lower in the DOR group than in controls [0.115 (0.058) vs 0.128 (0.040) ppb; p=0.032]. Within both cohorts, serum PCP correlated inversely with AMH (DOR: r=-0.268, p=0.039; control: r=-0.265, p=0.041). Serum PCP correlated positively with age only in controls (r=0.386, p=0.002). Conclusion: Serum PCP concentrations did not show a higher burden in women with DOR. However, the inverse within-cohort correlations between PCP and AMH suggest a possible endocrine signal that should be tested in larger longitudinal studies using repeated urine, serum, and follicular fluid measurements. These findings should be regarded as hypothesis-generating rather than causal. Because the analyses were exploratory, unadjusted, and based on multiple correlation tests, the results should be interpreted cautiously.

🔖

Cite This Article

Özalp, E., Akbulut, Ö. V., Çanga, K., Ağaoğlu, R. T., Aktaş, T. D., Seyhan, B., Kuşabbi, İ. A., Kahyaoğlu, İ. (2026). Serum pentachlorophenol levels in women with diminished ovarian reserve: a prospective cross-sectional case-control study. Journal of Health Sciences and Medicine, Volume: 9 Issue: 4. https://doi.org/10.32322/jhsm.1937321

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Practice Committee of the American Society for Reproductive Medicine. Definition of infertility: a committee opinion. Fertil Steril. 2023;120(6):1170. doi:10.1016/S0015-0282(23)01971-4
  2. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-1157. doi:10.1016/j.fertnstert.2020.09.134
  3. Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-1624. doi:10.1093/humrep/der092
  4. Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017;217(2):129-140. doi:10.1016/j.ajog.2017.02.027
  5. Richardson MC, Guo M, Fauser BCJM, Macklon NS. Environmental and developmental origins of ovarian reserve. Hum Reprod Update. 2014;20(3):353-369. doi:10.1093/humupd/dmt057
  6. Vabre P, Gatimel N, Moreau J, et al. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health. 2017;16(1):37. doi:10.1186/s12940-017-0242-4
  7. Parent AS, Damdimopoulou P, Johansson HKL, et al. Endocrine-disrupting chemicals and female reproductive health: a growing concern. Nat Rev Endocrinol. 2025;21(10):593-607. doi:10.1038/s41574-025-01131-x
  8. Land KL, Miller FG, Fugate AC, Hannon PR. The effects of endocrine-disrupting chemicals on ovarian- and ovulation-related fertility outcomes. Mol Reprod Dev. 2022;89(12):608-631. doi:10.1002/mrd.23652
  9. Toxicological Profile for Pentachlorophenol. Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2022.
  10. Guyton KZ, Loomis D, Grosse Y, et al. Carcinogenicity of pentachlorophenol and some related compounds. Lancet Oncol. 2016; 17(12):1637-1638. doi:10.1016/S1470-2045(16)30513-7
  11. Orton F, Lutz I, Kloas W, Routledge EJ. Endocrine disrupting effects of herbicides and pentachlorophenol: in vitro and in vivo evidence. Environ Sci Technol. 2009;43(6):2144-2150. doi:10.1021/es8028928
  12. Sun W, Jia Y, Ding X, et al. Combined effects of pentachlorophenol and its byproduct hexachlorobenzene on endocrine and reproduction in zebrafish. Chemosphere. 2019;220:216-226. doi:10.1016/j.chemosphere. 2018.12.100
  13. Huo Y, Wan Y, Li Y, et al. Associations of pentachlorophenol exposure during pregnancy with maternal and infant reproductive hormones based on a birth cohort. Sci Total Environ. 2024;932:172723. doi:10.1016/j.scitotenv.2024.172723
  14. Gerhard I, Frick A, Monga B, Runnebaum B. Pentachlorophenol exposure in women with gynecological and endocrine dysfunction. Environ Res. 1999;80(4):383-388. doi:10.1006/enrs.1998.3934
  15. Luo L, Qian X, Duan Y, et al. Association of pentachlorophenol in urine and follicular fluid with ovarian reserve and reproductive outcomes among women undergoing in vitro fertilization based on a prospective cohort study. Environ Res. 2025;270:120950. doi:10.1016/j.envres.2025.120950
  16. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596): 1453-1457. doi:10.1016/S0140-6736(07)61602-X
  17. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29(Suppl 1):S49-S52.
  18. Hallberg I, Bjorvang RD, Hadziosmanovic N, et al. Associations between lifestyle factors and levels of per- and polyfluoroalkyl substances, phthalates and parabens in follicular fluid in women undergoing fertility treatment. J Expo Sci Environ Epidemiol. 2023;33(5):699-709. doi:10.1038/s41370-023-00579-1
  19. Klimowska A, Jurewicz J, Radwan M, Radwan P, Pol P, Wielgomas B. Distribution of environmental phenols into follicular fluid and urine of women attending infertility clinic. J Xenobiot. 2025;15(1):17. doi:10. 3390/jox15010017
  20. Dimitriadis I, Souter I, Williams PL, et al. Phenol biomarker concentrations in human ovarian follicular fluid and the associations with in-vitro fertilization outcomes. Int J Hyg Environ Health. 2025;268: 114617. doi:10.1016/j.ijheh.2025.114617
  21. Bjorvang RD, Hallberg I, Pikki A, et al. Follicular fluid and blood levels of persistent organic pollutants and reproductive outcomes among women undergoing assisted reproductive technologies. Environ Res. 2022;208:112626. doi:10.1016/j.envres.2021.112626
  22. Yao W, Liu C, Qin DY, et al. Associations between phthalate metabolite concentrations in follicular fluid and reproductive outcomes among women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment. Environ Health Perspect. 2023;131(12):127019. doi:10.1289/EHP11998
  23. Genard-Walton M, McGee G, Williams PL, et al. Mixtures of urinary concentrations of phenols and phthalate biomarkers in relation to the ovarian reserve among women attending a fertility clinic. Sci Total Environ. 2023;898:165536. doi:10.1016/j.scitotenv.2023.165536
  24. Czubacka E, Wielgomas B, Klimowska A, et al. Urinary bisphenol A concentrations and parameters of ovarian reserve among women from a fertility clinic. Int J Environ Res Public Health. 2021;18(15):8041. doi:10.3390/ijerph18158041
  25. Jurewicz J, Radwan M, Wielgomas B, et al. Parameters of ovarian reserve in relation to urinary concentrations of parabens. Environ Health. 2020;19(1):26. doi:10.1186/s12940-020-00580-3